Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

COLLAGEN TO SEEK REMOVAL OF PM/DM WARNING FROM ZYDERM, ZYPLAST

This article was originally published in The Gray Sheet

Executive Summary

COLLAGEN TO SEEK REMOVAL OF PM/DM WARNING FROM ZYDERM, ZYPLAST labeling before the end of the year, the firm says. The company believes the FDA-mandated reference to polymyositis/dermatomyositis is unwarranted based on two years of additional data gathered since the warning was put in labeling for the injectable bovine collagen products.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002102

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel